Page 3 of 4
ChemComm
undergoes copperꢀcatalyzed aerobic dehydrogenation reaction 30 It’s noteworthy that copper catalyst in this reaction could
to generate E/Z isomers of intermediate B.9 The Eꢀisomer of
intermediate could undergo isomerization reaction to
generate its Zꢀisomer through intermediate C, and finally it
could afford the product 3aa through copper catalyzed
promote three mechanistically distinct transformations of azaꢀ
Michael addition, aerobic dehydrogenation and intramolecular
amidation. Wide substrate scope, mild reaction condition, and
air as oxidant are also significant advantages of this reaction.
B
5
intramolecular amide bond formation. Because the reaction 35 Further application of this method is underway in our
was conducted under air atmosphere, the formed Cu(I) species
in this reaction could be oxidized by air to Cu(II), so that the
reaction can be catalytic in Cu with air as terminal oxidant.
laboratory.
We thank the National Natural Science Foundation of
China (Grant 21032001 and 21272085). We also thank Dr.
Chuanqi Zhou for his help in performing HRMS analysis and
10 It’s noteworthy that Cu(OAc)2ꢁH2O played two critical roles
in this reaction, which could not only catalyze the 40 Dr. Xianggao Meng for performing Xꢀray diffraction analysis.
intermolecular C–N bond formation through azaꢀMichaial
addition/aerobic dehydrogenation, but also catalyze the
subsequent intramolecular cyclization via amide bond
15 formation.
Notes and references
1
E. G. Brown, Ring Nitrogen and Key Biomolecules: The
Biochemistry of N–heterocycles. Kluwer Academic: Boston, 1998.
J. J. Li and E. J. Corey, Name Reactions in Heterocyclic Chemistry.
Wiley–VCH: Weinheim, 2005; T. Eicher and S. Hauptmann, The
Chemistry of Heterocycles: Structure, Reactions, Syntheses, and
Applications. 2nd ed.; Wiley–VCH: Weinheim, Germany, 2003.
For some recent reviews and examples on Nꢀheterocycle synthesis
via copper–catalyzed aerobic oxidative C–N formation, see: C.
Zhang, C. Tang and N. Jiao, Chem. Soc. Rev., 2012, 41, 3464–3484;
A. E. Wendlandt, A. M. Suess and S. S. Stahl, Angew. Chem. Int.
Ed., 2011, 50, 11062–11087; S. R. Chemler and P. H. Fuller, Chem.
Soc. Rev., 2007, 36, 1153–1160; G. Brasche and S. L. Buchwald,
Angew. Chem. Int. Ed., 2008, 47, 1932–1934; H.ꢀF. He, Z.ꢀJ. Wang
and W. Bao, Adv. Synth. Catal., 2010, 352, 2905–2912; M. M.
Guru, M. A. Ali and T. Punniyamurthy, J. Org. Chem., 2011, 76,
5295–5308; R. L. Yan, H. Yan, C. Ma, Z. Y. Ren, X. A. Gao, G. S.
Huang and Y. M. Liang, J. Org. Chem., 2012, 77, 2024–2028; S.
Ueda and H. Nagasawa, J. Am. Chem. Soc., 2009, 131, 15080–
15081; L. Zhang, G. Y. Ang and S. Chiba, Org. Lett., 2010, 12,
3682–3685.
For some recent reviews and examples on autoꢀtandem catalysis, see:
N. Shindoh, Y. Takemoto and K. Takasu, Chem.–Eur. J., 2009, 15,
12168–12179; D. E. Fogg and E. N. dos Santos, Coord. Chem. Rev.,
2004, 248, 2365–2379; J.ꢀC. Wasilke, S. J. Obrey, R. T. Baker and
G. C. Bazan, Chem. Rev., 2005, 105, 1001–1020; Y. Yamamoto, J.
Org. Chem., 2007, 72, 7817; L. F. Tietze, Chem. Rev., 1996, 96, 115;
A. De Meijere, P. V. Zezschwitz and S. Bräse, Acc. Chem. Res.,
2005, 38, 413–422; K. Takasu, T. Tanaka, T. Azuma and Y.
Takemoto, Chem. Commun., 2010, 46, 8246–8248; M.ꢀZ. Wang, C.ꢀ
Y. Zhou and C.ꢀM. Che, Chem. Commun., 2011, 47, 1312–1314;
Y.ꢀQ. Zhang, D.ꢀY. Zhu, B.ꢀS. Li, Y.ꢀQ. Tu, J.ꢀX. Liu, Y. Lu and
S.ꢀH. Wang, J. Org. Chem., 2012, 77, 4167–4170.
I. Hermecz and Z. Mészáros, Med. Res. Rev., 1988, 8, 203–230; I.
Hermecz and L.Vasv´ariꢀDebreczy, Comprehensive Heterocyclic
Chemistry III, 2007, 12, 77–217, Vol. Ed. K. Jones Execut. Ed.: A.
R. Katritzky; C. Fenton and L. J. Scott, CNS Drugs, 2005, 19, 429–
444; F. Awouters, J. Vermeire, F. Smeyers, P. Vermote, R. Van
Beek and C. J. E. Niemegeers, Drug Dev. Res., 1986, 8, 95–102; L.
E. J. Kennis, F. P. Bischoff, C. J. Mertens, C. J. Love, F. A. F. Van
den Keybus, S. Pieters, M. Braeken, A. A. H. P. Megens and J. E.
Leysen, Bioorg. Med. Chem. Lett., 2000, 10, 71–74; R. L. Smith, R.
J. Barrett, E. SandersꢀBush, J. Pharmacol. Exp. Ther., 1995, 275,
1050–1057; A. Pettersson, K. Gradin, T. Hedner and B. Persson,
Naunyn-Schmiedeberg’s Arch. Pharmacol. 1985, 329, 394–397; S.
Matsutani and Y. Mizushima, Eur. Pat. Appl. 1989, EP 89ꢀ102635
19890216.
For some recent reviews and examples, see: I. Hermecz, Adv.
Heterocycl. Chem., 2003, 85, 173–285; J. Modranka and T. Janecki,
Tetrahedron, 2011, 67, 9595–9601; G. Bentabed–Ababsa, S. C. S.
Ely, S. Hesse, E. Nassar, F. Chevallier, T. T. Nguyen, A. Derdour,
and F. Mongin, J. Org. Chem., 2010, 75, 839–847; P. Čebašek, D.
Bevk, S. Pirc, B. Stanovnik and Svete, J. J. Comb. Chem., 2006, 8,
95–102; A. Begouin, S. Hesse, M.–J. R. P. Queiroz and G. Kirsch,
Synthesis, 2006, 2794–2798.
2
45
50
55
60
65
70
75
80
85
90
95
100
3
4
Scheme 2. Control experiments
5
Scheme 3. Proposed reaction mechanism
20
Considering the γꢀdiketone functional group in products
could easily undergo further transformation, we treated 3aa
with hydrazine hydrate in DMF, and a novel fused heterocycle
5aa was readily prepared in 81% yield (eq. 1). It's noteworthy
that this novel fused heterocycle scaffold of 5aa has never
6
25 been reported before.
7
8
M. Gao, Y. Yang, Y. D. Wu, C. Deng, L. P. Cao, X. G. Meng, and
A. X. Wu, Org. Lett., 2010, 12, 1856–1859.
CCDC 905791 (3qa) and 905792 (4ea) contain the supplementary
crystallographic data for this paper. For more details, see Supporting
Information.
D. Wang, Y. Shiraishi and T. Hirai, Chem. Commun., 2011, 47,
2673–2675.
In conclusion, we have developed a novel copper
catalyzed synthesis of 4Hꢀpyrido[1,2ꢀa]pyrimidinꢀ4ꢀones from
1,4ꢀenediones and 2ꢀaminoheterocycles with air as the oxidant.
9
This journal is © The Royal Society of Chemistry [year]
Journal Name, [year], [vol], 00–00 | 3